Unpacking the lipid–immune axis in health and disease
Immunology & Cell Biology · 2026
DOI: 10.1111/imcb.70076 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology & Cell Biology, 2026. Verfasst von Mortaza Raeisi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Lipid Metabolism, Lipids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 248 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences.
Abstract (Originalsprache)
The lipid–immune system relationship represents an important but overlooked axis of inflammation and host defense regulation. Radically different from an energy source or structural component, lipids influence immune cell regulation, signaling and inflammatory responses. This narrative review provides a broad overview of the role lipids play in immune regulation in both healthy and pathogenic states. We initiate the review by summarizing the role of a variety of lipid classes in immune cell biology, with an emphasis on explaining how lipid composition and metabolism influence both innate and adaptive immunity. Next, we analyze the role that lipid‐based mediators eicosanoids, resolvins and ceramides play in regulating inflammatory and pro‐resolving pathways. We observe dietary and circulatory lipids additionally direct the immune response and modulate the resolution of inflammatory processes. In diseases characterized by prolonged and persistent immune activation and low‐grade inflammation, such as atherosclerosis, obesity, type 2 diabetes and autoimmune diseases, impaired lipid metabolism ultimately aids this persistent state of immune activation. Moreover, we also consider the emergent role of the lipid‐immune interface in infectious disease, demonstrating ways in which pathogens can hijack or modify lipid metabolism to escape the host immune response. We cover the potential therapeutic implications of lipid–immune interactions, noting potential strategies using statins, omega‐3 fatty acids, or specialized lipid mediators, all with the objective of modulating inflammation rather than broad immunosuppression. Finally, we also identify important knowledge gaps and will suggest avenues for future research, particularly the need for more integrated lipidomic and immunologic studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Amir Mehdizadeh
Förderung
- Tabriz University of Medical Sciences
Zitieren
APA
Raeisi, M., Yousefi, M., Motavalli, R., Hassanzadeh, A., Seddighi, N., Mehri, M., Ebrahimi, S., Mehdizadeh, A., & Abbasi, K. (2026). Unpacking the lipid–immune axis in health and disease. Immunology & Cell Biology. https://doi.org/10.1111/imcb.70076
Vancouver
Raeisi M, Yousefi M, Motavalli R, Hassanzadeh A, Seddighi N, Mehri M, et al. Unpacking the lipid–immune axis in health and disease. Immunology & Cell Biology. 2026. doi:10.1111/imcb.70076
BibTeX
@article{Raeisi2026,
author = {Raeisi, Mortaza and Yousefi, Mehdi and Motavalli, Roza and Hassanzadeh, Ali and Seddighi, Narjes and Mehri, Maghsoud and Ebrahimi, Shiva and Mehdizadeh, Amir and Abbasi, Khadijeh},
title = {Unpacking the lipid–immune axis in health and disease},
journal = {Immunology & Cell Biology},
year = {2026},
doi = {10.1111/imcb.70076}
}
EUVIMED